Aytu Biopharma AYTU Balance Sheet (2011-2026)

NASDAQ AYTU
$2.20 +0.03 (+1.38%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Aytu Biopharma Quarterly Balance Sheet

Periods 59 quarters
Latest Jun 2026

Aytu Biopharma reported total assets of $105.01M and total liabilities of $69.73M for the quarter ended Jun 2026, down 15.4% year over year. This balance sheet covers 59 quarters of results from Aug 2011 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Feb2014 May2014 Sep2014 Dec2014 Feb2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
40.31M35.28M27.61M19.36M23.81M19.50M19.18M22.98M19.96M19.53M19.76M20.01M20.11M20.40M18.17M30.95M32.63M30.02M26.71M26.31M
Short-term InvestmentsInvestments (Current)
Cash & Current Investments
40.31M35.28M27.61M19.36M23.81M19.50M19.18M22.98M19.96M19.53M19.76M20.01M20.11M20.40M18.17M30.95M32.63M30.02M26.71M26.31M
Receivables - NetNet Receivables
21.63M22.99M27.61M21.71M27.92M25.55M34.04M28.94M29.90M29.40M29.93M23.53M23.16M25.40M35.83M31.16M33.23M30.92M24.49M22.78M
Receivables - OtherOther Receivables
0.01M
Receivables
21.64M22.99M27.61M21.71M27.92M25.55M34.04M28.94M29.90M29.40M29.93M23.53M23.16M25.40M35.83M31.16M33.23M30.92M24.49M22.78M
Raw Materials
2.64M2.43M1.80M1.81M2.11M1.79M2.22M1.30M1.97M1.65M1.85M0.27M0.72M0.49M0.54M1.11M1.37M1.21M1.37M1.14M
Work In Process
3.01M2.17M2.22M1.84M2.37M2.80M2.82M2.96M3.29M2.67M5.02M5.72M3.36M3.10M2.06M1.38M0.86M1.82M2.05M2.33M
Finished Goods
10.67M11.96M9.87M7.20M8.38M8.36M8.60M7.74M7.71M8.67M6.32M6.15M7.66M7.49M8.46M8.94M7.87M5.63M4.04M3.40M
Inventory
16.31M16.56M13.89M10.85M12.87M12.95M13.64M11.99M12.97M13.00M13.19M12.14M11.74M11.09M11.06M11.43M10.10M8.66M7.46M6.86M
Current Deferred Tax AssetsCurrent Deferred Tax
Prepaid Assets
9.34M11.30M7.94M7.38M9.02M11.99M10.43M7.16M7.04M8.11M7.25M5.10M5.73M6.17M7.46M5.64M5.15M6.64M8.66M5.81M
Current Assets
89.04M87.54M77.95M59.93M74.42M70.61M78.47M72.83M70.60M71.37M71.13M61.89M60.74M63.05M72.51M79.18M81.11M76.24M67.33M61.76M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
4.67M4.29M3.48M3.02M2.67M2.34M2.03M1.81M1.72M1.13M0.97M0.69M0.69M0.52M0.55M0.53M0.50M0.48M0.41M0.39M
Goodwill
46.35M46.35M8.64M
Intangibles
83.39M81.34M74.43M70.63M69.11M64.98M63.46M58.97M57.34M55.71M54.08M52.45M51.20M49.96M48.71M42.20M41.43M43.58M42.49M41.40M
Goodwill & Intangibles
129.73M127.69M83.06M70.63M69.11M64.98M63.46M58.97M57.34M55.71M54.08M52.45M51.20M49.96M48.71M42.20M41.43M43.58M42.49M41.40M
Long-Term Deferred Tax
0.10M
Other Non-Current Assets
0.47M0.46M0.77M0.77M0.83M0.82M0.89M2.54M0.77M0.91M0.89M2.19M1.97M1.52M1.32M1.20M0.94M0.74M0.56M0.60M
Non-Current Assets
138.69M136.28M90.88M77.69M75.58M70.83M68.75M65.38M62.29M59.88M57.73M56.20M55.09M53.17M51.69M45.00M43.88M45.76M44.36M43.25M
Assets
227.73M223.82M168.83M137.62M150.00M141.44M147.22M136.46M132.89M131.25M128.86M118.09M115.83M116.23M124.20M124.18M124.99M122.00M111.69M105.01M
Liabilities
Current Liabilities
Accounts Payables
9.38M15.60M11.13M10.99M14.67M10.58M14.67M13.48M14.47M10.47M10.47M10.31M13.51M11.70M12.04M10.60M12.34M14.26M13.21M11.28M
Notes Payables
3.81M7.43M10.40M1.56M1.22M1.03M1.58M2.40M4.27M4.01M
Payables
9.38M15.60M11.13M14.80M14.67M18.01M25.08M15.04M15.68M11.50M12.06M12.71M17.78M15.71M12.04M10.60M12.34M14.26M13.21M11.28M
Accumulated Expenses
54.38M50.69M53.47M44.19M41.43M41.22M49.59M46.80M40.73M43.41M44.09M38.14M33.72M39.37M41.73M38.16M36.70M40.16M34.27M35.20M
Other Accumulated Expenses
3.19M3.17M3.54M5.36M8.09M7.83M7.45M7.09M8.99M9.24M9.15M8.96M7.89M7.11M5.05M3.38M1.97M2.92M2.20M1.29M
Short term Debt
16.51M16.34M3.38M0.10M8.09M0.09M3.31M0.09M0.06M0.04M15.13M2.40M1.86M1.86M10.03M9.06M14.87M9.07M10.41M6.07M
Current Taxes
Current Deferred Revenue
Total Current Liabilities
98.00M100.57M80.36M64.44M73.20M67.15M85.42M69.02M65.46M64.19M83.69M62.23M61.25M64.05M70.71M63.06M65.99M65.56M59.97M54.66M
Non-Current Liabilities
Non-Current Debt
0.15M0.13M14.17M14.28M13.56M14.53M11.39M14.71M14.84M14.98M10.88M10.43M9.98M9.54M10.89M10.45M10.00M9.55M9.10M
Convertible Debt
Non-Current Deffered Revenue
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
0.10M0.10M
Operating Leases
2.76M2.72M2.41M
Other Non-Current Liabilities
8.17M8.30M5.58M12.80M9.33M9.78M7.92M6.97M12.31M12.89M8.61M12.74M9.40M6.39M4.94M26.33M20.42M27.34M4.84M4.77M
Total Non-Current Liabilities
108.06M109.99M102.11M80.52M92.32M85.84M98.38M28.09M88.41M34.21M14.40M28.15M24.75M21.41M18.60M42.15M35.82M42.24M16.57M15.07M
Total Liabilities
116.23M118.29M107.68M93.31M101.65M95.62M106.30M97.11M100.72M98.40M98.09M90.38M86.00M85.46M89.30M105.21M101.82M107.80M76.55M69.73M
Shareholder's Equity
Total Debt
16.66M16.47M17.55M18.19M21.65M22.05M25.09M16.36M16.12M16.04M16.72M15.67M16.56M15.85M19.56M19.96M25.32M19.07M19.96M15.18M
Common Equity
111.50M105.54M61.14M44.31M48.35M45.82M40.91M39.36M32.17M32.85M30.78M27.72M29.83M30.77M34.90M18.97M23.17M14.20M35.14M35.27M
Liabilities and Shareholders Equity
227.73M223.82M168.83M137.62M150.00M141.44M147.22M136.46M132.89M131.25M128.86M118.09M115.83M116.23M124.20M124.18M124.99M122.00M111.69M105.01M
Retained Earnings
-206.20M-217.70M-270.80M-287.10M-287.80M-294.50M-301.70M-304.13M-312.25M-312.50M-315.40M-319.97M-318.50M-317.71M-313.72M-333.54M-331.57M-342.15M-347.77M-347.79M
Preferred Shares

Aytu Biopharma Balance Sheet API

Pull Aytu Biopharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=AYTU&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY